In response to outbreaks of foot and mouth disease (FMD) and lumpy skin disease (LSD) in Indonesia in 2022, LiveCorp put forward a proposal aimed at leveraging the livestock export industry's long-term relationships with Indonesian trading partners to support emergency disease response and management efforts; in particular the uptake and access of LSD and FMD vaccines.

LiveCorp was provided with a $1.2 million grant as part of a $14 million Australian Government biosecurity package aimed to Manage the immediate risk of foot and mouth disease and lumpy skin disease to Australia.

Increasing livestock vaccination rates in Indonesia reduces the disease risk to imported Australian-bred cattle, while supporting the Indonesian cattle industry’s efforts to control the diseases has a flow-on effect to surrounding communities.

Activities under the grant included a feedlot/importer partial reimbursement vaccine program, support for the coordination and logistics of getting vaccines into communities surrounding feedlots holding Australian-bred cattle, smallholder farmer capacity building and outreach activities, local government agency training, biosecurity training for feedlot and abattoir workers, and engagement with the Indonesian Government.

The objective of the grant program was to increase effective LSD and FMD vaccination on the ground in Indonesia to contribute towards:

• lowering risk to Australia of an FMD or LSD incursion

• improving business confidence for trade in cattle between Australia and Indonesia

• supporting the food security of Indonesian communities by working with our trading partners.